Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 50,993 | 285,442 | 209,958 | 139,739 | 89,734 |
| Depreciation Amortization | 28,540 | 107,238 | 80,315 | 53,344 | 26,641 |
| Income taxes - deferred | -11,591 | -29,567 | -22,651 | -6,365 | -4,767 |
| Accounts receivable | 15,599 | -20,867 | -20,775 | 11,425 | 17,335 |
| Accounts payable and accrued liabilities | -2,695 | -7,908 | -5,647 | -11,541 | -1,401 |
| Other Working Capital | -19,977 | -90,577 | -79,706 | -40,313 | -22,932 |
| Other Operating Activity | -1,486 | 10,632 | 9,506 | -25,824 | -48,529 |
| Operating Cash Flow | $59,383 | $254,393 | $171,000 | $120,465 | $56,081 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,759 | 14,736 | 8,661 | 6,009 | 9 |
| PPE Investments | -13,592 | -38,244 | -27,413 | -15,665 | -9,556 |
| Net Acquisitions | -166,426 | -101,184 | -101,184 | -101,184 | -101,184 |
| Purchase Of Investment | 0 | N/A | -232,000 | N/A | N/A |
| Sale Of Investment | N/A | 91,043 | 91,043 | 91,043 | 91,043 |
| Other Investing Activity | 2,149 | -232,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-154,110 | $-265,649 | $-260,893 | $-19,797 | $-19,688 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 160,000 | 619,661 | 619,661 | 449,661 | 449,661 |
| Debt Repayment | -70,000 | -525,661 | -505,661 | -505,661 | -441,000 |
| Common Stock Issued | 14,394 | 29,813 | 21,399 | 16,977 | 11,950 |
| Common Stock Repurchased | N/A | -19,562 | -19,562 | -19,562 | -19,562 |
| Dividend Paid | -12,654 | -50,285 | -37,688 | -25,106 | -12,545 |
| Other Financing Activity | -20,228 | -31,350 | -31,311 | -20,310 | -20,310 |
| Financing Cash Flow | $71,512 | $22,616 | $46,838 | $-104,001 | $-31,806 |
| Exchange Rate Effect | -8,693 | -3,356 | -2,230 | -4,552 | -11,897 |
| Beginning Cash Position | 180,571 | 172,567 | 172,567 | 172,567 | 172,567 |
| End Cash Position | 148,663 | 180,571 | 127,282 | 164,682 | 165,257 |
| Net Cash Flow | $-31,908 | $8,004 | $-45,285 | $-7,885 | $-7,310 |
| Free Cash Flow | |||||
| Operating Cash Flow | 59,383 | 254,393 | 171,000 | 120,465 | 56,081 |
| Capital Expenditure | -13,592 | -38,244 | -27,413 | -15,665 | -9,556 |
| Free Cash Flow | 45,791 | 216,149 | 143,587 | 104,800 | 46,525 |